SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Staff Question Forest Laboratories, Inc., Nycomed Lung Drug

April 5, 2010 | 
1 min read
Reuters -- U.S. drug reviewers questioned the safety and effectiveness of a proposed lung drug from Forest Laboratories Inc (FRX.N) and Nycomed A/S [NYCMD.UL], documents released on Monday said.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Collage halftone banner with two hands that put objects on scales. Halftone hands holding circle and square and put them on the scales. Concept of business balance in teamwork. Vector illustration.
Legal
REGENXBIO Secures Legal Win in Gene Therapy Patent Battle Vs. Sarepta
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Created with Canva Dreamlab †
FDA
Makary, Prasad Under Fire as FDA Turmoil Reaches President Trump
February 20, 2026
 · 
6 min read
 · 
Heather McKenzie
The white plane flies against the blue sky, leaving a white trail. Vector illustration
Vaccines
ACIP Meeting Delayed as Turbulence Rocks CDC, US Vaccine Policy
February 20, 2026
 · 
2 min read
 · 
Tristan Manalac
Man hand with magnifying glass. Yellow ray coming from loupe. Conducting check, information search and analysis concept. Spy, accountant, auditor job in abstract style. High quality photo
Regulatory
FDA’s Top Drug Regulator To Probe Safety of Antidepressants, RSV Antibodies
February 20, 2026
 · 
2 min read
 · 
Tristan Manalac